Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: Discov Med. 2016 Jan;21(113):41–47.

Figure 1. Options for Gene Therapy in HNSCC.

Figure 1

Potential options for gene restoration in HNSCC, in this example for TP53. Gene editing of mutant TP53 or viral-mediated expression of WT TP53 are both potential options. An ideal gene therapy tool would incorporate 100% specificity, no footprint, no off target effects, selective tropism to HNSCC cells, and 100% efficacy.